SCOTUS upheld Medicare drug-price negotiation. The 10 negotiated drugs land where Black Medicare beneficiaries already absorb the disease burden.
The Supreme Court on May 18, 2026 declined to hear pharmaceutical-industry appeals to the Inflation Reduction Act's Medicare drug-price negotiation program. The 10 drugs negotiated for January 2026 are concentrated in cardiovascular, diabetes, and immunology …